Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...
WEDNESDAY, March 5, 2025 (HealthDay News) -- For patients with psoriasis, Amjevita and Imraldi are as effective as Humira for new users and in a switcher analysis, according to a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback